Page last updated: 2024-08-26

mizoribine and everolimus

mizoribine has been researched along with everolimus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Abe, T; Ichimaru, N; Imamura, R; Kaimori, JY; Kakuta, Y; Kato, T; Nonomura, N; Takahara, S; Yamanaka, K1
Harada, S; Ito, T; Koshino, K; Nakamura, T; Nakao, T; Nobori, S; Suzuki, T; Ushigome, H; Yoshimura, N1
Manabe, S; Nagata, M; Nitta, K1

Reviews

1 review(s) available for mizoribine and everolimus

ArticleYear
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
    Contributions to nephrology, 2018, Volume: 195

    Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases

2018

Other Studies

3 other study(ies) available for mizoribine and everolimus

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Risk factors and incidence for lipid abnormalities in kidney transplant patients.
    Transplantation proceedings, 2015, Volume: 47, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Cyclosporine; Dyslipidemias; Everolimus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Mycophenolic Acid; Ribonucleosides; Risk Factors; Tacrolimus

2015
Effectiveness of the Combination of Everolimus and Tacrolimus With High Dosage of Mizoribine for Living Donor-Related Kidney Transplantation.
    Transplantation proceedings, 2016, Volume: 48, Issue:3

    Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Ribonucleosides; Tacrolimus; Transplant Recipients; Young Adult

2016